Julia Guzova
Pre-Doctoral Trainee
Boston University School of Medicine, Graduate Medical Sciences
Dept of Pharmacology & Experimental Therapeutics




Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Guzova JA, Primiano MJ, Jiao A, Stock J, Lee C, Winkler AR, Hall JP. Corrigendum to "Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells" [Journal of Immunological Methods 467 (2019) 19-28]. J Immunol Methods. 2019 May; 468:67. PMID: 30947983
     
  2. Guzova JA, Primiano MJ, Jiao A, Stock J, Lee C, Winkler AR, Hall JP. Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells. J Immunol Methods. 2019 04; 467:19-28. PMID: 30735689
     
  3. Lovering F, Morgan P, Allais C, Aulabaugh A, Brodfuehrer J, Chang J, Coe J, Ding W, Dowty H, Fleming M, Frisbie R, Guzova J, Hepworth D, Jasti J, Kortum S, Kurumbail R, Mohan S, Papaioannou N, Strohbach JW, Vincent F, Lee K, Zapf CW. Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors. Eur J Med Chem. 2018 Feb 10; 145:606-621. PMID: 29348070
     
  4. Primiano MJ, Lefker BA, Bowman MR, Bree AG, Hubeau C, Bonin PD, Mangan M, Dower K, Monks BG, Cushing L, Wang S, Guzova J, Jiao A, Lin LL, Latz E, Hepworth D, Hall JP. Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation. J Immunol. 2016 Sep 15; 197(6):2421-33.View Related Profiles. PMID: 27521339; DOI: 10.4049/jimmunol.1600035;
     
  5. Boue S, Fields B, Hoeng J, Park J, Peitsch MC, Schlage WK, Talikka M, Binenbaum I, Bondarenko V, Bulgakov OV, Cherkasova V, Diaz-Diaz N, Fedorova L, Guryanova S, Guzova J, Igorevna Koroleva G, Kozhemyakina E, Kumar R, Lavid N, Lu Q, Menon S, Ouliel Y, Peterson SC, Prokhorov A, Sanders E, Schrier S, Schwaitzer Neta G, Shvydchenko I, Tallam A, Villa-Fombuena G, Wu J, Yudkevich I, Zelikman M. Enhancement of COPD biological networks using a web-based collaboration interface. F1000Res. 2015; 4:32. PMID: 25767696; DOI: 10.12688/f1000research.5984.1;
     
  6. LaBranche TP, Jesson MI, Radi ZA, Storer CE, Guzova JA, Bonar SL, Thompson JM, Happa FA, Stewart ZS, Zhan Y, Bollinger CS, Bansal PN, Wellen JW, Wilkie DP, Bailey SA, Symanowicz PT, Hegen M, Head RD, Kishore N, Mbalaviele G, Meyer DM. JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production. Arthritis Rheum. 2012 Nov; 64(11):3531-42. PMID: 22899318; DOI: 10.1002/art.34649;
     
  7. Baima ET, Guzova JA, Mathialagan S, Nagiec EE, Hardy MM, Song LR, Bonar SL, Weinberg RA, Selness SR, Woodard SS, Chrencik J, Hood WF, Schindler JF, Kishore N, Mbalaviele G. Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides. J Biol Chem. 2010 Apr 30; 285(18):13498-506. PMID: 20167598; PMCID: PMC2859510; DOI: 10.1074/jbc.M109.099895;
     
  8. Chiang PC, Hu Y, Thurston A, Sommers CD, Guzova JA, Kahn LE, Lai Y, Blom JD. Pharmacokinetic and pharmacodynamic evaluation of the suitability of using fluticasone and an acute rat lung inflammation model to differentiate lung versus systemic efficacy. J Pharm Sci. 2009 Nov; 98(11):4354-64. PMID: 19230021; DOI: 10.1002/jps.21714;
     
  9. Bonafoux DF, Bonar SL, Clare M, Donnelly AM, Glaenzer JL, Guzova JA, Huang H, Kishore NN, Koszyk FJ, Lennon PJ, Libby A, Mathialagan S, Oburn DS, Rouw SA, Sommers CD, Tripp CS, Vanella LJ, Weier R, Wolfson SG, Huang HC. Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship. Bioorg Med Chem. 2010 Jan 1; 18(1):403-14. PMID: 19914076; DOI: 10.1016/j.bmc.2009.10.040;
     
  10. Sommers CD, Thompson JM, Guzova JA, Bonar SL, Rader RK, Mathialagan S, Venkatraman N, Holway VW, Kahn LE, Hu G, Garner DS, Huang HC, Chiang PC, Schindler JF, Hu Y, Meyer DM, Kishore NN. Novel tight-binding inhibitory factor-kappaB kinase (IKK-2) inhibitors demonstrate target-specific anti-inflammatory activities in cellular assays and following oral and local delivery in an in vivo model of airway inflammation. J Pharmacol Exp Ther. 2009 Aug; 330(2):377-88. PMID: 19478133; DOI: 10.1124/jpet.108.147538;
     
Showing 10 of 15 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 15 publications over 11 distinct years, with a maximum of 4 publications in 2009

YearPublications
19961
19981
20031
20051
20094
20101
20121
20151
20161
20171
20192

Contact for Mentoring:

Guzova's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department